US 11285163
Ophthalmic solution
granted A61KA61K2300/00A61K31/5377
Quick answer
US patent 11285163 (Ophthalmic solution) held by SENTISS PHARMA PRIVATE LIMITED expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SENTISS PHARMA PRIVATE LIMITED
- Grant date
- Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2300/00, A61K31/5377, A61K31/542, A61K31/5575